TORONTO, ONTARIO / ACCESS Newswire / November 11, 2025 / Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV:DM)(FSE:D4G)(OTC:DTMXF) is pleased to announce the closing date for both the non-brokered private placement of shares and subscription receipt financing (collectively, the “Offerings”), as previously disclosed in the Company’s press release dated September 29, 2025. The Company intends to close both Offerings on November 14, 2025.
Pursuant to the Offerings, the Company intends to issue up to an aggregate of up to 50,000,000 common shares at a price of $0.08 per share for gross proceeds of up to $4,000,000, and up to 16,250,000 subscription receipts (the “Subscription Receipts”) at a price of $0.08 per Subscription Receipt, for gross proceeds of up to $1,300,000.
The net proceeds from the Offerings will be used for the Company’s existing business expansion, development, new location, the integration of the Yuzu Payment Solution into Datametrex’s technology division, and general working capital.
The Company may pay finder’s fees of up to 5% cash, 5% shares, and 10% warrants, or up to 10% cash and 10% warrants, in connection with both Offerings, all in accordance with the policies of the TSX Venture Exchange.
All securities issued and issuable pursuant to the Offerings will be subject to a statutory hold period of four months plus one day from the date of issuance, in accordance with applicable Canadian securities laws.
About Datametrex
Datametrex is an innovative leader in Technology Solutions, Artificial Intelligence, and Healthcare. The Company specializes in delivering tools and solutions that enhance operational efficiencies and business outcomes. With a commitment to innovation, Datametrex is dedicated to supporting enterprises by setting a new standard for business protocols through cutting-edge technology.
For more on Datametrex, please visit our Company website.
For Additional Information
Paul Haber, C.P.A., C.A., C.Dir
CEO & Chairman
[email protected]
(416) 318-6501
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release is not an offer to sell or the solicitation of an offer to buy the securities in the United States or in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to qualification or registration under the securities laws of such jurisdiction. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and such securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from U.S. registration requirements and applicable U.S. state securities laws.
Forward-Looking Statements
This news release contains “forward-looking statements,” which involve risks, uncertainties, and factors that could cause actual results to differ materially from those anticipated. These statements are not historical facts and are generally identified by words such as “expects,” “plans,” “anticipates,” “believes,” “intends,” “estimates,” “projects,” and similar expressions. Such statements include expectations related to healthcare business and other Company plans.
While Datametrex believes the forward-looking information is reasonable as of the date of this release, these statements involve assumptions, risks, and uncertainties that could cause actual outcomes to differ. Key factors include general economic conditions, legislative and regulatory developments, access to capital, industry competition, and the Company’s ability to execute its strategies. The Company does not undertake to update these statements, except as required by law. Readers are advised not to place undue reliance on forward-looking information.
Factors that could cause actual results to differ materially are detailed under “Risk Factors” in Datametrex’s management’s discussion and analysis and available on the Company’s profile at http://www.sedarplus.ca.
This release does not constitute an offer to sell or a solicitation to buy, nor shall it constitute an offer, solicitation, or sale in any jurisdiction where such would be unlawful prior to registration or qualification under applicable securities laws. We seek Safe Harbor.
SOURCE: Datametrex AI Ltd.
